Pricing Log in Create free account
Saturday 17 October 2026 Export ILMN’s income statement to Excel — free account

Illumina, Inc.

ILMN Healthcare Diagnostics & Research

Illumina, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue grew 9.44%, EPS fell 8.05%, free cash flow fell 18.3% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

262.03 5.90 −2.20%
Market cap
$40.5B
P/E
48.4×
Fwd P/E
34.7×
Dividend yield
—
F-score
8/9
Altman Z
4.39
Beneish M
−2.51
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Illumina, Inc. (ILMN) Debt to equity

Alert me on Debt to equity

Illumina, Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 0.5×, down 0.0× from fiscal 2025 (0.5×). Over the past ten years it has ranged from 0.2× (fiscal 2021) to 0.6× (fiscal 2024); the current reading is higher than 82% of that period. That is above the Diagnostics & Research industry median of 0.1× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2025 0.5× (12.85%)
FY2024 0.6× 142.25%
FY2023 0.3× 15.05%
FY2022 0.2× 42.78%
FY2021 0.2× (37.43%)
FY2020 0.3× (1.91%)
FY2019 0.3× (50.50%)
FY2018 0.5× 19.79%
FY2017 0.4× (6.97%)
FY2016 0.5× (21.00%)

Quarterly newest first

Period Debt to equity Change
Jun 2026 0.5× (5.64%)
Mar 2026 0.6× 1.75%
Dec 2025 0.5× 31.07%
Sep 2025 0.4× (36.82%)
42 more quarters

Against its own ten years

Low 0.2× High 0.6×
Ten-year median 0.4×
Current reading's percentile 82

Debt to equity against peers

Company Debt to equity
NTRA Natera, Inc. compare 0.0×
IDXX IDEXX Laboratories, Inc. compare 0.3×
WAT Waters Corporation compare 0.3×
A Agilent Technologies, Inc. compare 0.5×
ILMN Illumina, Inc. 0.5×
LH Labcorp Holdings Inc. compare 0.7×
DGX Quest Diagnostics Incorporated compare 0.7×
IQV IQVIA Holdings Inc. compare 2.5×
MTD Mettler-Toledo International, Inc. compare 165×
Diagnostics & Research industry median 0.1×
Healthcare sector median 0.0×
Market median 0.1×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on ILMN